PS
HAE icon

Principal Securities’s Haemonetics HAE Stock Holding History

Principal Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30
Closed -$1.46K – 2266
2025
Q3 		$1.46K Sell
30
-62
-67% -$3.84K ﹤0.01% 3309
2025
Q2 		$6.86K Buy
92
+83
+922% +$5.5K ﹤0.01% 2775
2025
Q1 		$703 Hold
9
– – ﹤0.01% 3286
2024
Q4 		$703 Hold
9
– – ﹤0.01% 3279
2024
Q3 		$723 Sell
9
-6
-40% -$485 ﹤0.01% 3207
2024
Q2 		$1.24K Buy
15
+6
+67% +$528 ﹤0.01% 3018
2024
Q1 		$768 Hold
9
– – ﹤0.01% 3081
2023
Q4 		$770 Buy
+9
New +$778 ﹤0.01% 3006

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Securities's HAE Position: Q4 2025 in Review

Principal Securities sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 30 shares — an estimated $1.46K sold.

Principal Securities first reported a position in HAE in Q4 2023 and held it in 8 quarters. The position peaked at $6.86K in Q2 2025. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Principal Securities reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 30 Haemonetics shares in Q4 2025, an estimated $1.46K.
  • Principal Securities first reported a position in Haemonetics in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Haemonetics position peaked at $6.86K in Q2 2025.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.